Bi-weekly intravenous cyclophosphamide as remission induction therapy for pediatric vasculitis.

被引：0
|
作者：
Bracaglia, Claudia
Cortis, Elisabetta
Zurakowski, David
Sundel, Robert P.
机构：
[1] Osped Bambino Gesu, Rome, Italy
[2] Childrens Hosp, Boston, MA 02115 USA
来源：
ARTHRITIS AND RHEUMATISM | 2006年 / 54卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4060 / 4060
页数：1
相关论文
共 50 条
  • [41] Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY)
    Ohtani, Shoichiro
    Nakayama, Takahiro
    Yoshinami, Tetsuhiro
    Watanabe, Ken-ichi
    Hara, Fumikata
    Sagara, Yasuaki
    Kawaguchi, Hidetoshi
    Higaki, Kenji
    Matsunami, Nobuki
    Hasegawa, Yoshie
    Takahashi, Masato
    Mizutani, Makiko
    Morimoto, Takashi
    Sato, Masako
    Itoh, Mitsuya
    Morita, Satoshi
    Masuda, Norikazu
    BREAST CANCER, 2018, 25 (04) : 438 - 446
  • [42] A randomized trial of mycophenolate mofetil versus cyclophosphamide for remission induction of ANCA-associated vasculitis: "MYCYC". On behalf of the European vasculitis study group
    Jones, R.
    Harper, L.
    Ballarin, J.
    Blockmans, D.
    Brogan, P.
    Bruchfeld, A.
    Cid, M.
    Dahlsveen, K.
    Dezoysa, J.
    Lanyon, P.
    Peh, C. A.
    Tesar, V.
    Vaglio, A.
    Walsh, M.
    Walsh, D.
    Walters, G.
    Jayne, D.
    PRESSE MEDICALE, 2013, 42 (04): : 678 - 679
  • [43] The utility of bi-weekly eribulin therapy for metastatic breast cancer: A Japanese multicenter phase II study (JUST-STUDY)
    Yoshinami, Tetsuhiro
    Masuda, Norikazu
    Nakayama, Takahiro
    Hara, Fumikata
    Sagara, Yasuaki
    Kawaguchi, Hidetoshi
    Watanabe, Ken-ichi
    Sato, Masako
    Aogi, Kenjiro
    Higaki, Kenji
    Morimoto, Takashi
    Shigeoka, Yasushi
    Tokunaga, Shinya
    Morishima, Hirotaka
    Yanagita, Yasuhiro
    Tsurutani, Junji
    Baba, Shinichi
    Katayama, Kazuhisa
    Morita, Satoshi
    Ohtani, Shoichiro
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [44] Phase I-II study of DaICM-P [daily dalteparin (Dal), cyclophosphamide (C) and prednisone (P) and bi-weekly methotrexate (M)] as therapy for metastatic breast cancer (MBC).
    Buckman, RA
    Wong, NS
    Clemons, M
    Verma, S
    Trudeau, ME
    Roche, K
    Kerbel, RS
    Deboer, G
    Sutherland, DJ
    Pritchard, KI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 52S - 52S
  • [45] Pulse Versus Daily Oral Cyclophosphamide for Induction of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis A Randomized Trial
    de Groot, Kirsten
    Harper, Lorraine
    Jayne, David R. W.
    Suarez, Luis Felipe Flores
    Gregorini, Gina
    Gross, Wolfgang L.
    Luqmani, Rashid
    Pusey, Charles D.
    Rasmussen, Niels
    Sinico, Renato A.
    Tesar, Vladimir
    Vanhille, Philippe
    Westman, Kerstin
    Savage, Caroline O. S.
    ANNALS OF INTERNAL MEDICINE, 2009, 150 (10) : 670 - U3
  • [46] Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis
    de Groot, K
    Rasmussen, N
    Bacon, PA
    Tervaert, JWC
    Feighery, C
    Gregorini, G
    Gross, WL
    Luqmani, R
    Jayne, DRW
    ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2461 - 2469
  • [47] Randomised controlled trial of daily oral versus pulse cyclophosphamide for induction of remission in ANCA-associated systemic vasculitis
    de Groot, K
    Jayne, DRW
    Tesar, V
    Savage, COS
    KIDNEY & BLOOD PRESSURE RESEARCH, 2005, 28 (03): : 195 - 195
  • [48] Mycophenolate mofetil versus cyclophosphamide for remission induction in ANCA-associated vasculitis: a randomised, non-inferiority trial
    Jones, Rachel B.
    Hiemstra, Thomas F.
    Ballarin, Jose
    Blockmans, Daniel Engelbert
    Brogan, Paul
    Bruchfeld, Annette
    Cid, Maria C.
    Dahlsveen, Karen
    de Zoysa, Janak
    Espigol-Frigole, Georgina
    Lanyon, Peter
    Peh, Chen Au
    Tesar, Vladimir
    Vaglio, Augusto
    Walsh, Michael
    Walsh, Dorothy
    Walters, Giles
    Harper, Lorraine
    Jayne, David
    Salama, Alan D.
    Milford, David
    Kluth, David
    Luqmani, Raashid
    Flossmann, Oliver
    Short, Andrew
    Baildam, Eileen
    Stoves, John
    Erwig, Lars
    Christian, Martin
    Savage, Caroline O.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 (03) : 399 - 405
  • [49] Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis (CYCLOPS study)
    Koetter, I.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (07): : 575 - 577
  • [50] COMPARISON OF EFFICACY AND SAFETY BETWEEN RITUXIMAB AND CYCLOPHOSPHAMIDE IN REMISSION INDUCTION THERAPY FOR JAPANESE ANCA-ASSOCIATED VASCULITIS(AAV) PATIENTS; A SINGLE CENTER RETROSPECTIVE ANALYSIS
    Kato, M.
    Shimada, H.
    Nakashima, S.
    Mansour, M. Mahmoud Fahmy
    Wakiya, R.
    Miyagi, T.
    Sugihara, K.
    Ushio, Y.
    Kameda, T.
    Dobashi, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1540 - 1540
12345